Catalyst Pharm Inc
(CPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,509 | -12,155 | -4,076 | -6,391 | -4,006 |
| Depreciation Amortization | 27 | 23 | 11 | 43 | 26 |
| Accounts payable and accrued liabilities | 963 | -515 | 1,102 | 158 | -144 |
| Other Working Capital | 769 | 190 | -285 | 627 | -227 |
| Other Operating Activity | 808 | 2,581 | -1,892 | 579 | 594 |
| Operating Cash Flow | $-12,942 | $-9,876 | $-5,140 | $-4,985 | $-3,757 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8,980 | -9,979 | -7,504 | 0 | N/A |
| PPE Investments | -57 | -9 | -52 | -4 | -3 |
| Other Investing Activity | 296 | 2,491 | -6,503 | 0 | 0 |
| Investing Cash Flow | $-8,741 | $-7,497 | $-14,060 | $-4 | $-3 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 5,000 | N/A | N/A |
| Common Stock Issued | 28,564 | 18,179 | 9,581 | 5,543 | 1,456 |
| Financing Cash Flow | $28,564 | $18,179 | $14,581 | $5,543 | $1,456 |
| Beginning Cash Position | 2,216 | 1,410 | 6,029 | 5,475 | 7,779 |
| End Cash Position | 9,097 | 2,216 | 1,410 | 6,029 | 5,475 |
| Net Cash Flow | $6,881 | $806 | $-4,619 | $554 | $-2,304 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,942 | -9,876 | -5,140 | -4,985 | -3,757 |
| Capital Expenditure | -57 | -9 | -52 | -4 | -3 |
| Free Cash Flow | -12,999 | -9,885 | -5,193 | -4,989 | -3,760 |